A detailed history of Advisor Group Holdings, Inc. transactions in Evotec Se stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 466 shares of EVO stock, worth $2,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares
466
Previous 332 40.36%
Holding current value
$2,083
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.96 - $5.34 $396 - $715
134 Added 40.36%
466 $1,000
Q2 2024

Aug 13, 2024

BUY
$4.07 - $7.87 $1,351 - $2,612
332 New
332 $1,000
Q3 2023

Nov 13, 2023

BUY
$9.63 - $13.36 $799 - $1,108
83 Added 461.11%
101 $0
Q2 2023

Aug 10, 2023

BUY
$8.95 - $12.48 $161 - $224
18 New
18 $0

Others Institutions Holding EVO

About Evotec SE


  • Ticker EVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 353,904,992
  • Market Cap $1.58B
  • Description
  • Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...
More about EVO
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.